Trials

We are advancing potential first-in-class Live Biotherapeutic Products (LBP), a category of therapeutics that the U.S. Food and Drug Administration (FDA) uses to denote biologic products that contain defined compositions of live organisms, are not vaccines, and are used for the prevention or treatment of human disease.